Adaptin Bio (APTN) Free Cash Flow (2023 - 2026)

Adaptin Bio's Free Cash Flow history runs 4 years deep, the most recent figure standing at -$596298.0 for Q1 2026.

• In Q1 2026, Free Cash Flow rose 73.85% year-over-year to -$596298.0; the TTM figure through Mar 2026 stood at -$3.1 million (down 8.98% YoY), while the FY2025 annual figure was -$4.8 million, down 635.87% from the prior year.
• Free Cash Flow came in at -$596298.0 for Q1 2026 at Adaptin Bio, up from -$702876.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $112653.0 in Q4 2024 to a low of -$2.3 million in Q1 2025.
• A 4-year average of -$608182.0 and a median of -$532357.0 in 2024 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 293.07% in 2024 and slumped 2441.81% in 2025, its largest moves.
• Adaptin Bio's Free Cash Flow stood at -$58347.0 in 2023, then jumped by 293.07% to $112653.0 in 2024, then tumbled by 723.93% to -$702876.0 in 2025, then rose by 15.16% to -$596298.0 in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$596298.0, -$702876.0, and -$772430.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison